CHRISTOPHER KEETON: Open Payments
NPI 1316037740 · PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,140 in 130 payments from 19 companies in 2025. Trend: 2023 $1,793 · 2024 $1,903 · 2025 $2,140
Food & beverage: $2,140
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $403 |
| Novo Nordisk Inc | 21 | $286 |
| Lilly USA, LLC | 22 | $274 |
| ABBVIE INC. | 14 | $244 |
| Amgen Inc. | 12 | $173 |
| PFIZER INC. | 14 | $160 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $64 |
| Collegium Pharmaceutical, Inc. | 4 | $61 |
| GlaxoSmithKline, LLC. | 4 | $59 |
Products named: AIRSUPRA, VRAYLAR, MOUNJARO, JARDIANCE, Wegovy, Kerendia, OTEZLA, BREZTRI.
Industry payments across OH — which companies pay providers there.
